✦ LIBER ✦

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

✍ Scribed by Rosa Sánchez; Emilio Esteban; Isabel Palacio; Yolanda Fernández; Isabel Muñiz; Jose M. Vieitez; Joaquin Fra; Pilar Blay; Noemí Villanueva; Esther Uña; Beatriz Mareque; Enrique Estrada; Jose M. Buesa; Angel J. Lacave

Book ID: 111558553
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 59 KB
Volume: 21
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1026207519884

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly chemotherapy with irinotecan plus

Weekly chemotherapy with irinotecan plus a taxane in advanced non small cell lung cancer (NSCLC)

✍ Rich, R.S; Argiris, A; Peccerillo, K; McKeon, A; Gallipoli, M; Burtness, B.A; Mu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Salvage treatment of taxane-refractory a

Salvage treatment of taxane-refractory advanced non-small-cell lung cancer with a cisplatin plus irinotecan (CPT-11) combination

✍ Kakolyris, S; Androulakis, N; Agelaki, S; Mavroudis, D; Souglakos, J; Vardakis, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Irinotecan (CPT-11) in combination with

Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer

✍ Kunihiko Kobayashi; Ayako Shinbara; Mitsuhiro Kamimura; Yuichiro Takeda; Koichir 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 405 KB

Cisplatin and irinotecan (CPT-11) as sec

Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer

✍ Kakolyris, S; Kouroussis, Ch; Souglakos, J; Agelaki, S; Kalbakis, K; Vardakis, N 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB

P-344 Celecoxib combined with weekly iri

P-344 Celecoxib combined with weekly irinotecan (CPT-11) and docetaxel for the treatment of patients with advanced non-small cell lung cancer (NSCLC)

✍ Argiris, Athanassios 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Weekly irinotecan (CPT-11) in 5-FU heavi

Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer

✍ M. Benavides; P. García-Alfonso; M. Cobo; A. Muñoz-Martín; S. Gil-Calle; F. Cara 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 88 KB